López-Narváez ML, González-Castro TB, Castillo-Ávila RG, Juárez-Rojop IE, Tovilla-Zárate CA

Language: Spanish
References: 30
Page: 180-183
PDF size: 217.64 Kb.

ABSTRACT

Introduction: information on epidemiological aspects is important for decision-making. The aim of this study was to describe the demographic and clinical characteristics of pediatric patients with COVID-19 who were cared for in the state of Chiapas, Mexico, during the first year of the pandemic. Material and methods: the information from the Open Data of the General Directorate of Epidemiology of the Ministry of Health of Mexico, of the cases of COVID-19 registered from 2020 to April 22, 2021, was analyzed. Results: during the study period, 1,153 Mexican pediatric patients were treated. The distribution by sex was similar, corresponding to 50.7% (n = 584) of male patients. By age, the majority were patients younger than two years, and between 12 and 18 years. Seventy-one patients (6.2%) had pneumonia, and 2.2% (n = 25) required intubation. Nineteen patients (1.6%) died. Conclusion: the data from this study showed that pediatric patients with COVID-19 treated in Chiapas had similar characteristics to those described in other parts of the world.

REFERENCES

1. Zhu N, Zhang D, Wang W et al. A novel coronavirus from patients with pneumonia in China, 2019. New Engl J Med. 2020; 382: 727-733.

2. Guan W-j, Ni Z-y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382: 1708-1720.

3. Montaño-Luna VE, Miranda-Novales MG. Actualización del manejo clínico de COVID-19 en pediatría: a un año de pandemia. Rev Mex Pediatr. 2021;88(1):31-45.

4. Sohrabi C, Alsafi Z, O'Neill N et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020; 76: 71-76.

5. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020; 91: 157-160.

6. Rizo-Patron E, Padilla J, Tantaleán JA. Demanda hospitalaria pediátrica en tiempos de COVID-19. Acta Med Peru. 2020; 37: 376-381.

7. Chan JF, Yuan S, Kok KH et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395: 514-523.

8. Marginean CO, Melit LE, Simu I et al. Pediatric COVID-19: low incidence, but possible fatality-a case report and a review of the literature. Children (Basel). 2021; 8(12): 1128.

9. Siebach MK, Piedimonte G, Ley SH. COVID-19 in childhood: transmission, clinical presentation, complications and risk factors. Pediatr Pulmonol. 2021; 56: 1342-1356.

10. Hyde Z. Difference in SARS-CoV-2 attack rate between children and adults may reflect bias. Clin Infect Dis. 2022; 74(1): 152-155.

11. Mansourian M, Ghandi Y, Habibi D et al. COVID-19 infection in children: A systematic review and meta-analysis of clinical features and laboratory findings. Arch Pediatr. 2021; 28: 242-248.

12. Jiang L, Tang K, Levin M et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis. 2020; 20: e276-e88.

13. Gobierno de México S. COVID-19 México: Tasa de incidencia de casos acumulados por entidad federativa de residencia 2021. Disponible en: https://datos.covid-19.conacyt.mx/

14. Lee PI, Hu YL, Chen PY et al. Are children less susceptible to COVID-19? J Microbiol Immunol Infect. 2020; 53(3): 371-372.

15. Kaushik A, Gupta S, Sood M et al. A systematic review of multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection. Pediatr Infect Dis J. 2020; 39(11): e340-e346.

16. Ruíz-Quiñonez JA, Guzmán-Priego CG, Nolasco-Rosales GA et al. Features of patients that died for COVID-19 in a hospital in the south of Mexico: a observational cohort study. Plos One. 2021; 16(2): e0245394.

17. Pearson AA, Prado AM, Colburn FD. The puzzle of COVID-19 in Central America and Panama. J Glob Health. 2021; 11: 03077.

18. México Gd. Dirección General de Epidemiología Datos abiertos Ciudad de México: Secretaría de Salud; 2021. Disponible en: https://www.gob.mx/salud/documentos/datos-abiertos-bases-historicas-direccion-general-de-epidemiologia?idiom=es

19. Henry BM, Benoit SW, de Oliveira MHS et al. Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): a pooled analysis and review. Clin Biochem. 2020; 81: 1-8.

20. Seth S, Rashid F, Khera K. An overview of the COVID-19 complications in paediatric population: a pandemic dilemma. Int J Clin Pract. 2021; 75(9): e14494.

21. Dong Y, Mo X, Hu Y et al. Epidemiological characteristics of 2,143 pediatric patients with 2019 coronavirus disease in China. J Emerg Med. 2020; 58(4): 712-713.

22. Lu X, Zhang L, Du H et al. SARS-CoV-2 infection in children. N Engl J Med. 2020; 382: 1663-1665.

23. Lazzerini M, Sforzi I, Trapani S et al. Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020. Euro Surveill. 2021; 26(14): 2001248.

24. Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020; 323(14): 1335.

25. Parri N, Lenge M, Buonsenso D. Children with Covid-19 in pediatric emergency Departments in Italy. N Engl J Med. 2020; 383(2): 187-190.

26. Bellino S, Punzo O, Rota MC et al. COVID-19 disease severity risk factors for pediatric patients in Italy. Pediatrics. 2020; 146(4): e2020009399.

27. Tagarro A, Epalza C, Santos M et al. Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain. JAMA Pediatrics. 2021; 175: 316-317.

28. Calvo C, Tagarro A, Otheo E et al. [Epidemiological update on SARS-CoV-2 infection in Spain. Comments on the management of infection in pediatrics]. An Pediatr (Engl Ed). 2020; 92(4): 239-240.

29. Team CC-R. Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69: 422-426.

30. Leidman E, Duca LM, Omura JD et al. COVID-19 trends among persons aged 0-24 years - United States, March 1-December 12, 2020. MMWR Morb Mortal Wkly Rep. 2021; 70: 88-94.